Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conor O'Shea

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The American Journal of Cardiology|October 7, 2004
Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy)Abdallah G Rebeiz, Jean-Pierre Dery, Anastasios A Tsiatis, et al.
The Canadian Journal of Cardiology|August 12, 2009
Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) studyMina Madan, Janarthan Nikhil, Anne S Hellkamp, et al.
The American Journal of Cardiology|December 14, 2002
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living aloneJ Conor O'Shea, Robert G Wilcox, Allan M Skene, et al.
Irish Journal of Medical Science|January 15, 2020
The role of primary care in management of rare diseases in IrelandNiall Byrne, Jacqueline Turner, Rita Marron, et al.
The Canadian Journal of Cardiology|December 1, 2004
A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stentingMina Madan, Marino Labinaz, Eric A Cohen, et al.
JAMA|February 7, 2002
Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent interventionJ Conor O'Shea, Christopher E Buller, Warren J Cantor, et al.
American Heart Journal|June 15, 2018
Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI)Noel M Caplice, Mary C DeVoe, Janet Choi, et al.
Journal of Medical Internet Research|December 6, 2022
Assessment of Clinical Information Quality in Digital Health Technologies: International eDelphi StudyKayode Philip Fadahunsi, Petra A Wark, Nikolaos Mastellos, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The American Journal of Cardiology|October 7, 2004
Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy)Abdallah G Rebeiz, Jean-Pierre Dery, Anastasios A Tsiatis, et al.
The Canadian Journal of Cardiology|August 12, 2009
Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) studyMina Madan, Janarthan Nikhil, Anne S Hellkamp, et al.
The American Journal of Cardiology|December 14, 2002
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living aloneJ Conor O'Shea, Robert G Wilcox, Allan M Skene, et al.
Irish Journal of Medical Science|January 15, 2020
The role of primary care in management of rare diseases in IrelandNiall Byrne, Jacqueline Turner, Rita Marron, et al.
The Canadian Journal of Cardiology|December 1, 2004
A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stentingMina Madan, Marino Labinaz, Eric A Cohen, et al.
JAMA|February 7, 2002
Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent interventionJ Conor O'Shea, Christopher E Buller, Warren J Cantor, et al.
American Heart Journal|June 15, 2018
Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI)Noel M Caplice, Mary C DeVoe, Janet Choi, et al.
Journal of Medical Internet Research|December 6, 2022
Assessment of Clinical Information Quality in Digital Health Technologies: International eDelphi StudyKayode Philip Fadahunsi, Petra A Wark, Nikolaos Mastellos, et al.
Pageof 4